The oncogenic role of hepatitis delta virus in hepatocellular carcinoma.

Puigvehí, Marc; Moctezuma-Velázquez, Carlos; Villanueva, Augusto; Llovet, Josep M

Puigvehí, Marc; Moctezuma-Velázquez, Carlos; Villanueva, Augusto; Llovet, Josep M.

Afiliação

Puigvehí M; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Moctezuma-Velázquez C; Hepatology Section, Gastroenterology Department, Hospital del Mar, IMIM, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain.
Villanueva A; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Llovet JM; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

JHEP Rep ; 1(2): 120-130, 2019 Aug.

Article em En | MEDLINE | ID: mdl-32039360

Palavras-chave

HCC, co-infection; Hepatitis B virus; defective; liver cancer; molecular pathogenesis; superinfection

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: JHEP Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google